Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hovinga, J.
Right arrow Articles by Lammle, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hovinga, J.
Right arrow Articles by Lammle, B
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Coagulation factor XII Locarno: the functional defect is caused by the amino acid substitution Arg 353-->Pro leading to loss of a kallikrein cleavage site

JK Hovinga, J Schaller, H Stricker, WA Wuillemin, M Furlan and B Lammle

Central Hematology Laboratory, Inselspital, Bern, Switzerland.

The dysfunctional coagulation factor XII (FXII) Locarno was purified from 2 L of the proposita's plasma. Studies to identify the molecular defect responsible for the lack of amidolytic and proteolytic activity of this FXII variant were performed. Amino acid sequence analysis of peptides obtained from FXII Locarno on activation with either trypsin or plasma kallikrein and dextran sulfate showed an amino acid substitution of Arg 353 by Pro. Thereby, the kallikrein cleavage site at Arg 353-Val 354 is lost. Although trypsin-activated FXII Locarno was fully cleaved at Arg 334-Asn 335 and at Arg 343-Leu 344, neither amidolytic nor proteolytic activity was generated. We conclude that proteolytic cleavage at Arg 343 in the absence of cleavage at Arg 353 is not sufficient to expose the enzymatic active site in FXII Locarno.

Volume 84, Issue 4, pp. 1173-1181, 08/15/1994
Copyright © 1994 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
A. Girolami, S. Gavasso, E. Pacquola, L. Cabrio, A. M. Lombardi, and B. Girolami
Comparable Levels of Activity and Antigen in Factor XII Deficiency: A Study of 21 Homozygotes and 58 Heterozygotes
Clinical and Applied Thrombosis/Hemostasis, July 1, 2005; 11(3): 335 - 338.
[Abstract] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
N. Fujihara, M. Tozuka, K. Yamauchi, I. Ueno, N. Urasawa, S. Ishikawa, M. Hirota-Kawadobora, N. Okumura, H. Hidaka, and T. Katsuyama
Characterization of Factor XII Tenri, a Rare CRM-Negative Factor XII Deficiency
Ann. Clin. Lab. Sci., April 1, 2004; 34(2): 218 - 225.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Kondo, F. Tokunaga, S. Kawano, Y. Oono, S. Kumagai, and T. Koide
Factor XII Tenri, a Novel Cross-Reacting Material Negative Factor XII Deficiency, Occurs Through a Proteasome-Mediated Degradation
Blood, June 15, 1999; 93(12): 4300 - 4308.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Schloesser, S. Zeerleder, G. Lutze, W.-M. Halbmayer, S. Hofferbert, B. Hinney, H. Koestering, B. Lammle, G. Pindur, K. Thies, et al.
Mutations in the Human Factor XII Gene
Blood, November 15, 1997; 90(10): 3967 - 3977.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1994 by American Society of Hematology         Online ISSN: 1528-0020